Top of page
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation
You are here: Main Content

Dr Stephen Bright

Senior Lecturer

Staff Member Details
Telephone: +61 8 6304 863042597
Campus: Joondalup  
Room: JO31.471R  

Dr Bright oversees the development and delivery of curriculum pertaining to the use of Alcohol and Other Drugs (AOD) in the context of society.


Stephen has worked as a psychologist within the Mental Health & AOD field for the past 15 years. He is currently Senior Lecturer of Addiction at Edith Cowan University. Stephen is a strong advocate of harm reduction and an evidence-based approach to AOD legislation. He is also interested in the role of certain substances (entheogens) to facilitate spiritual experiences, and their role in psychotherapy.

His PhD related to the public perceptions and media portrayal of AOD use and the implications of this for drug-related harm, including the rapid emergence of new psychoactive substances. This has led to the development of a project that aims to make the Australian media more accountable when reporting on AOD issues:

Stephen is a leading Australian voice on the role of drug policy on emerging drug trends such as synthetic cannabis and darkweb marketplaces.

Professional Associations

  • Founding member and vice-president of PRISM, a not-for-profit organisation that aims to fund positive AOD research.
  • Elected member of the Victorian Alcohol and Drug Association (VAADA) board since 2015
  • Member of the AOD Media Watch Reference Group
  • Peninsula Health's Human Research Ethics Committee since 2012

Awards and Recognition

  • 2012: Awarded a Gold Medal in the Victorian Public Health Awards
  • 2011: Awarded best late breaking paper at the APSAD conference

Research Areas and Interests

  • Alcohol and Other Drug (AOD) policy.
  • AOD and the media
  • Emerging drug trends.
  • Psychedelics.
  • Synthetic cannabis.
  • MDMA-assisted psychotherapy.
  • Harm reduction.
  • Role of stigma among people who use drugs
  • Older adults and alcohol.


  • Doctor of Philosophy, Curtin University of Technology, 2015.
  • Bachelor of Arts Psychology With Fist Class Honours, Edith Cowan University, 2006.
  • BA (Psych) hons., Edith Cowan University, 2005.

Research Outputs

Journal Articles

  • Underwood, M., Bright, S., Lancaster, L. (2021). A narrative review of the pharmacological, cultural and psychological literature on ibogaine. Journal of Psychedelic Studies, Online Early(Online Early), N/A.
  • Wilkinson, C., Clark, K., Sambell, R., Dare, J., Bright, S. (2021). The health of older Western Australians: the role of age, gender, geographic location, psychological distress, perceived health, tobacco and alcohol. Advances In Dual Diagnosis: Policy, Practice And Research In Mental Health And Substance Use, Online Early(Online Early), N/A.
  • Bright, S., Blatchford, E., Gringart, E., Bettinson, S. (2021). A quantitative exploration of the relationships between regular yoga practice, microdosing psychedelics, wellbeing and personality variables. Australian Journal of Psychology, Accepted(Accepted), N/A.
  • Murphy, S., Dear, G., Bright, S. (2021). Could a drug-checking service increase intention to use ecstasy at a festival?. Drug and Alcohol Review, Online Early(Online Early), N/A.

Journal Articles

  • Bright, S., Milroy, J., Walsh, K., Blatchford, E. (2020). Medication use among older Australians seeking alcohol and other drug treatment. Australasian Journal on Ageing, 39(3), 287-291.
  • Blatchford, E., Bright, S., Engel, L. (2020). Tripping over the other: Could psychedelics increase empathy?. Journal of Psychedelic Studies, 4(3), 163-170.
  • Engel, L., Bright, S., Barratt, M., Allen, M. (2020). Positive drug stories: possibilities for agency and positive subjectivity for harm reduction. Addiction Research and Theory, 2020(Article in press), 1-9.

Journal Articles

  • Banister, S., Adams, A., Kevin, R., Macdonald, C., Glass, M., Boyd, R., Connor, M., McGregor, I., Havel, C., Bright, S., Vilamala, M., Lladanosa, C., Barratt, M., Gerona, R. (2019). Synthesis and pharmacology of new psychoactive substance 5F‐CUMYL‐P7AICA, a scaffold‐ hopping analog of synthetic cannabinoid receptor agonists 5F‐CUMYL‐PICA and 5F‐CUMYL‐PINACA. Drug Testing and Analysis, 11(2), 279-291.

Journal Articles

  • Bright, S., Williams, M. (2018). Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research. Australian Psychologist, 53(6), 467-476.
  • Bright, S., Williams, C. (2018). Evaluation of Australia’s first older adult-specific early intervention for reducing alcohol-related harm. Australian Health Review, 42(6), 676-679.
  • Bright, S., Walsh, K., Williams, C. (2018). Point Prevalence and Patterns of Mental Health Comorbidity Among People Accessing Australia's First Older Adult-Specific Alcohol and Other Drug Treatment Service. Journal of Dual Diagnosis, 14(1), 70-75.

Journal Articles

  • Bright, S., Williams, C. (2017). Development of Australia’s first older adult-specific early intervention for alcohol-related harm: Feasibility and proof of concept. Australasian Journal on Ageing, 36(1), 52-55.

Journal Articles

  • Bright, S., Fink, A., Beck, J., Gabriel, J., Singh, D. (2015). Development of an Australian version of the Alcohol-Related Problems Survey: A comprehensive computerised screening tool for older adults. Australasian Journal on Ageing, 34(1), 33-37.

Journal Articles

Journal Articles

  • Bright, S., Bishop, B., Kane, R., Marsh, A., Barratt, M. (2013). Kronic hysteria: Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. International Journal of Drug Policy, 24(3), 231-237.
  • Bright, S., Kane, R., Marsh, A., Bishop, B. (2013). Psychometric Properties of the Locus of Control of Behaviour Scale (LCBS) among Australians Seeking Alcohol and Other Drug (AOD) Treatment. Australian Psychologist, 48(3), 172-177.

Research Projects

  • Can the quality of life of young adults with Chronic Inflammatory Arthritis [CIA] be improved through participation in a DRUMBEAT© program?, Healthway (WA Health Promotion Foundation), Health Promotion Project Grant, 2019 ‑ 2020, $5,000.
  • Systematic review of chain analysis research for suicide prevention, Edith Cowan University, ECU Grant in Aid Scheme, 2018 ‑ 2019, $4,947.
  • An Open Label Pilot Study of MDMA-Assisted Manualised Psychotherapy among Australians with Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD), Edith Cowan University, School of Medical and Health Sciences Research Grant Scheme 2018, 2018 ‑ 2019, $8,498.

Research Student Supervision

Associate Supervisor

  • Master of Science (Medical Science), DRUMBEAT© for arthritis “a shared purpose” rather than a “lonely struggle”
No data available
Skip to top of page